BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bill Gates Pledges $258 Million To Fight Malaria


10/31/2005 10:50:00 AM

Microsoft Corp. founder Bill Gates has pledged $258.3 million for research and development to combat malaria, including new cash to test the world's first vaccine against the mosquito-borne disease. Gates, who is providing three grants via the Bill & Melinda Gates Foundation, said it was a "disgrace" that the world had allowed malaria deaths to double in the last 20 years, when so much could be done to prevent the disease. Malaria kills 2,000 African children every day. The largest of the grants, $107.6 million, will go to a vaccine initiative working with GlaxoSmithKline Plc on late-stage clinical trials of its experimental vaccine, Mosquirix. The vaccine has already produced promising results in clinical trials but will not be available until after 2010.

Read at Reuters

Reuters
   
Malaria

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES